NCT01639703View on ClinicalTrials.gov

Hepatic Xenetix-CT Perfusion

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Xenetix-CT perfusion imaging

Injection of 50 ml of Xenetix

Trial Locations (5)

Unknown

AKH, Vienna

Universitätsklinikum Erlangen, Erlangen

SMC, Seoul

SNUH, Seoul

Zurich University Hospital, Zurich

Sponsors

Lead Sponsor

Guerbet
All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT01639703 - Hepatic Xenetix-CT Perfusion | Biotech Hunter | Biotech Hunter